A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05572515 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05572515
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2025-10-13
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.